PBYINasdaq United States
Market cap
$453.514 M
$8.91 +9.73%
Close of 7 Aug 2026
Revenue
$228.4M
#2258 by revenue
Earnings
$31.1M
#1743 by earnings
Shares outstanding
51,620,066
Latest filing cover page
P/E ratio
14.6
Cap ÷ net income
Where these numbers come from
Share counts and financials for Puma Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.